These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 16567424)
1. Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation. Yoshida H; Okamoto K; Iwamoto T; Sakai E; Kanaoka K; Hu JP; Shibata M; Hotokezaka H; Nishishita K; Mizuno A; Kato Y J Biochem; 2006 Mar; 139(3):583-90. PubMed ID: 16567424 [TBL] [Abstract][Full Text] [Related]
2. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling. Yamashita M; Otsuka F; Mukai T; Yamanaka R; Otani H; Matsumoto Y; Nakamura E; Takano M; Sada KE; Makino H Regul Pept; 2010 Jun; 162(1-3):99-108. PubMed ID: 20346376 [TBL] [Abstract][Full Text] [Related]
3. A novel PPARgamma agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways. Park JY; Bae MA; Cheon HG; Kim SS; Hong JM; Kim TH; Choi JY; Kim SH; Lim J; Choi CH; Shin HI; Kim SY; Park EK Biochem Biophys Res Commun; 2009 Jan; 378(3):645-9. PubMed ID: 19059209 [TBL] [Abstract][Full Text] [Related]
4. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor. Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600 [TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling. Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257 [TBL] [Abstract][Full Text] [Related]
6. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109 [TBL] [Abstract][Full Text] [Related]
7. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Huang H; Chang EJ; Ryu J; Lee ZH; Lee Y; Kim HH Biochem Biophys Res Commun; 2006 Dec; 351(1):99-105. PubMed ID: 17052691 [TBL] [Abstract][Full Text] [Related]
8. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells. Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913 [TBL] [Abstract][Full Text] [Related]
10. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation. Tsuji-Naito K Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786 [TBL] [Abstract][Full Text] [Related]
11. The mechanism of osteoclast differentiation induced by IL-1. Kim JH; Jin HM; Kim K; Song I; Youn BU; Matsuo K; Kim N J Immunol; 2009 Aug; 183(3):1862-70. PubMed ID: 19587010 [TBL] [Abstract][Full Text] [Related]
12. Bavachalcone inhibits osteoclast differentiation through suppression of NFATc1 induction by RANKL. Park CK; Lee Y; Chang EJ; Lee MH; Yoon JH; Ryu JH; Kim HH Biochem Pharmacol; 2008 Jun; 75(11):2175-82. PubMed ID: 18433733 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of osteoclast differentiation and bone resorption by sauchinone. Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251 [TBL] [Abstract][Full Text] [Related]
14. Momordin I, an inhibitor of AP-1, suppressed osteoclastogenesis through inhibition of NF-kappaB and AP-1 and also reduced osteoclast activity and survival. Hwang YH; Lee JW; Hahm ER; Jung KC; Lee JH; Park CH; Rhee HS; Ryu JM; Kim HK; Yang CH Biochem Biophys Res Commun; 2005 Nov; 337(3):815-23. PubMed ID: 16213465 [TBL] [Abstract][Full Text] [Related]
15. Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos. Ha J; Choi HS; Lee Y; Lee ZH; Kim HH Int Immunopharmacol; 2009 Jun; 9(6):774-80. PubMed ID: 19285574 [TBL] [Abstract][Full Text] [Related]
16. Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues. Sasaki H; Yamamoto H; Tominaga K; Masuda K; Kawai T; Teshima-Kondo S; Matsuno K; Yabe-Nishimura C; Rokutan K Free Radic Biol Med; 2009 Jul; 47(2):189-99. PubMed ID: 19409483 [TBL] [Abstract][Full Text] [Related]
17. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling. Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790 [TBL] [Abstract][Full Text] [Related]
18. The molecular understanding of osteoclast differentiation. Asagiri M; Takayanagi H Bone; 2007 Feb; 40(2):251-64. PubMed ID: 17098490 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in the enhancement of osteoclast formation by enamel matrix derivative. Itoh N; Kasai H; Ariyoshi W; Harada E; Yokota M; Nishihara T J Periodontal Res; 2006 Aug; 41(4):273-9. PubMed ID: 16827720 [TBL] [Abstract][Full Text] [Related]
20. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation. Ichikawa H; Murakami A; Aggarwal BB Mol Cancer Res; 2006 Apr; 4(4):275-81. PubMed ID: 16603641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]